Pulmonary gas exchange on the summit of Mount Everest.

Design and conduct of Caudwell Xtreme Everest: an observational cohort study of variation in human adaptation to progressive environmental hypoxia. BMC Med Res Methodol (2010) 1.09

Oxygen-dependent expression of cytochrome c oxidase subunit 4-2 gene expression is mediated by transcription factors RBPJ, CXXC5 and CHCHD2. Nucleic Acids Res (2013) 1.01

Acid-base balance at exercise in normoxia and in chronic hypoxia. Revisiting the "lactate paradox". Eur J Appl Physiol (2003) 0.96

Safety and exercise tolerance of acute high altitude exposure (3454 m) among patients with coronary artery disease. Heart (2005) 0.92

Career perspective: John B West. Extrem Physiol Med (2012) 0.83

Mitochondrial function at extreme high altitude. J Physiol (2015) 0.83

High-altitude illnesses: physiology, risk factors, prevention, and treatment. Rambam Maimonides Med J (2011) 0.81

A strategy for determining arterial blood gases on the summit of Mt. Everest. BMC Physiol (2006) 0.77

Effects of high altitude on sleep and respiratory system and theirs adaptations. ScientificWorldJournal (2013) 0.76

The heart and lungs at extreme altitude. Thorax (1994) 0.75

Thin Air Resulting in High Pressure: Mountain Sickness and Hypoxia-Induced Pulmonary Hypertension. Can Respir J (2017) 0.75

Thoraco-abdominal coordination and performance during uphill running at altitude. PLoS One (2017) 0.75

Everest 60 years on: what next? Extrem Physiol Med (2013) 0.75

Spirometry and respiratory muscle function during ascent to higher altitudes. Lung (2007) 0.75

[Respiratory system at high altitude: pathophysiology and novel therapy options]. Wien Klin Wochenschr (2011) 0.75

The incidence, importance, and prophylaxis of acute mountain sickness. Lancet (1976) 5.69

Predicting error in rigid-body point-based registration. IEEE Trans Med Imaging (1998) 4.93

Misrepresentation and responsibility in medical research. N Engl J Med (1987) 3.20

Comparison of intravenous and nebulised salbutamol in initial treatment of severe asthma. Br Med J (1978) 2.82

The distribution of target registration error in rigid-body point-based registration. IEEE Trans Med Imaging (2001) 2.74

Measurement of continuous distributions of ventilation-perfusion ratios: theory. J Appl Physiol (1974) 2.24

Crystalloid vs. colloid resuscitation: is one better? A randomized clinical study. Surgery (1979) 2.06

Rales, peripheral edema, retinal hemorrhage and acute mountain sickness. Am J Med (1979) 1.89

Continuous distributions of ventilation-perfusion ratios in normal subjects breathing air and 100 per cent O2. J Clin Invest (1974) 1.86

Distribution of mechanical stress in the lung, a possible factor in localisation of pulmonary disease. Lancet (1971) 1.84

Sleep, performance, circadian rhythms, and light-dark cycles during two space shuttle flights. Am J Physiol Regul Integr Comp Physiol (2001) 1.76

Vertical gradient of alveolar size in lungs of dogs frozen intact. J Appl Physiol (1967) 1.73

Measurements of capillary dimensions and blood volume in rapidly frozen lungs. J Appl Physiol (1969) 1.69

Acute mountain sickness. Thorax (1983) 1.61

NO-mediated activation of heme oxygenase: endogenous cytoprotection against oxidative stress to endothelium. Am J Physiol (1996) 1.58

Barometric pressures at extreme altitudes on Mt. Everest: physiological significance. J Appl Physiol Respir Environ Exerc Physiol (1983) 1.58

Ventilation-perfusion inequality and overall gas exchange in computer models of the lung. Respir Physiol (1969) 1.56

Hemodynamic changes with cirrhosis of the liver: control of arteriovenous shunts during operation for esophageal varices. Ann Surg (1966) 1.53

Frontiers of hypoxia research: acute mountain sickness. J Exp Biol (2001) 1.53

Predicted gas exchange on the summit of Mt. Everest. Respir Physiol (1980) 1.51

Nucleotide sequence and genetic organization of the genome of the N-specific filamentous bacteriophage IKe. Comparison with the genome of the F-specific filamentous phages M13, fd and f1. J Mol Biol (1985) 1.51

Intense exercise impairs the integrity of the pulmonary blood-gas barrier in elite athletes. Am J Respir Crit Care Med (1997) 1.48

Ultrastructural appearances of pulmonary capillaries at high transmural pressures. J Appl Physiol (1985) (1991) 1.47

Survival of patients ventilated in an intensive therapy unit. Br Med J (1979) 1.46

Arterial blood pressure responses to cell-free hemoglobin solutions and the reaction with nitric oxide. J Biol Chem (1998) 1.45

Stresses, strains, and surface pressures in the lung caused by its weight. J Appl Physiol (1972) 1.44

Microgravity reduces sleep-disordered breathing in humans. Am J Respir Crit Care Med (2001) 1.43

Effect of lung volume on the distribution of pulmonary blood flow in man. Respir Physiol (1968) 1.43

The great oxygen secretion controversy. Lancet (1986) 1.42

A comparison of slow-release salbutamol with slow-release aminophylline in nocturnal asthma. J Int Med Res (1979) 1.40

Ventilation-perfusion inequality in chronic obstructive pulmonary disease. J Clin Invest (1977) 1.39

Introduction to a previously unpublished paper by A. M. Kellas. High Alt Med Biol (2001) 1.38

The rates of synthesis and chain elongation of ribonucleic acid in Escherichia coli. J Biol Chem (1969) 1.38

Effects of extraerythrocytic hemoglobin and its components on mononuclear cell procoagulant activity. J Lab Clin Med (1992) 1.38

Sodium balance, fluid homeostasis and the renin-aldosterone system during the prolonged exercise of hill walking. Clin Sci (Lond) (1982) 1.38

Heme oxygenase-1-derived carbon monoxide contributes to the suppression of acute hypertensive responses in vivo. Circ Res (1998) 1.37

A consequence of the rel gene during a glucose to lactate downshift in Escherichia coli. The rates of ribonucleic acid synthesis. J Biol Chem (1971) 1.37

Site-specific PEGylation of hemoglobin at Cys-93(beta): correlation between the colligative properties of the PEGylated protein and the length of the conjugated PEG chain. Bioconjug Chem (2003) 1.34

State of the art: ventilation-perfusion relationships. Am Rev Respir Dis (1977) 1.34

Adequacy of available respirators to their tasks. Ann Thorac Surg (1967) 1.30

Microvascular and tissue oxygen distribution. Cardiovasc Res (1996) 1.27

Ventilation-perfusion inequality in asymptomatic asthma. Am Rev Respir Dis (1978) 1.27

Effect of the exercise of seven consecutive days hill-walking on fluid homeostasis. Clin Sci (Lond) (1979) 1.25

Dispersion of 0.5- to 2-micron aerosol in microG and hypergravity as a probe of convective inhomogeneity in the lung. J Appl Physiol (1985) (1999) 1.25

Postpneumonectomy pulmonary edema. J Thorac Cardiovasc Surg (1984) 1.23

High altitude pulmonary edema and exercise at 4,400 meters on Mount McKinley. Effect of expiratory positive airway pressure. Chest (1985) 1.23

Crystalloid versus colloid in fluid resuscitation of patients with severe pulmonary insufficiency. Surg Gynecol Obstet (1984) 1.22

Effect of microgravity and hypergravity on deposition of 0.5- to 3-micron-diameter aerosol in the human lung. J Appl Physiol (1985) (1997) 1.21

The role of facilitated diffusion in oxygen transport by cell-free hemoglobins: implications for the design of hemoglobin-based oxygen carriers. Biophys Chem (2001) 1.20

inlA premature stop codons are common among Listeria monocytogenes isolates from foods and yield virulence-attenuated strains that confer protection against fully virulent strains. Appl Environ Microbiol (2008) 1.19

Deposition and dispersion of 1-micrometer aerosol boluses in the human lung: effect of micro- and hypergravity. J Appl Physiol (1985) (1998) 1.19

Effects of diffusion impairment on O 2 and CO 2 time courses in pulmonary capillaries. J Appl Physiol (1972) 1.17

Coordinate control of ribonucleic acid synthesis during uracil deprivation. J Biol Chem (1969) 1.17

Respiratory effects and amnesia after premedication with morphine or lorazepam. Br J Anaesth (1977) 1.16

High lung volume increases stress failure in pulmonary capillaries. J Appl Physiol (1985) (1992) 1.15

Peptide chain synthesis of human hemoglobins A and A2. J Biol Chem (1966) 1.15

Amino acid regulation of the rates of synthesis and chain elongation of ribonucleic acid in Escherichia coli. J Biol Chem (1969) 1.14

Relationship of hypoxic ventilatory response to exercise performance on Mount Everest. J Appl Physiol Respir Environ Exerc Physiol (1984) 1.13

Human physiology at extreme altitudes on Mount Everest. Science (1984) 1.11

Respiratory function in the morbidly obese before and after weight loss. Thorax (1989) 1.10

Arterial oxygen saturation for prediction of acute mountain sickness. Aviat Space Environ Med (1998) 1.10

Finite element displacement analysis of a lung. J Biomech (1972) 1.08

Valvar regurgitation in acute infective endocarditis: early replacement. Arch Surg (1970) 1.07

Control of the hyperdynamic circulation in patients with bleeding esophageal varices. Ann Surg (1969) 1.07

Nonsurgical treatment of splenic hemorrhage in an adult with infectious mononucleosis. Case report and review. Am J Med (1986) 1.07

Subunit dissociations in natural and recombinant hemoglobins. Protein Sci (1996) 1.07

Causes of carbon dioxide retention in lung disease. N Engl J Med (1971) 1.06

Complications of the flow-directed pulmonary artery catheter: A prospective analysis in 219 patients. Crit Care Med (1981) 1.06

Fluid retention and relative hypoventilation in acute mountain sickness. Respiration (1982) 1.06

Reliability of gallium scan chest radiography compared to mediastinoscopy for evaluating mediastinal spread in lung cancer. Am Rev Respir Dis (1978) 1.06

Microalbuminuria in chronic obstructive lung disease. BMJ (1993) 1.05

Exchange of subunit interfaces between recombinant adult and fetal hemoglobins. Evidence for a functional inter-relationship among regions of the tetramer. J Biol Chem (1997) 1.05

Multiorgan scans for staging lung cancer. Correlation with clinical evaluation. J Thorac Cardiovasc Surg (1977) 1.04

Acetazolamide in the treatment of acute mountain sickness: clinical efficacy and effect on gas exchange. Ann Intern Med (1992) 1.04

Progress in the development of RBC substitutes. Transfusion (2001) 1.03

Red cell function at extreme altitude on Mount Everest. J Appl Physiol Respir Environ Exerc Physiol (1984) 1.03

Alveolar hypoxia increases gene expression of extracellular matrix proteins and platelet-derived growth factor-B in lung parenchyma. Am J Respir Crit Care Med (1998) 1.03

Maximal exercise at extreme altitudes on Mount Everest. J Appl Physiol Respir Environ Exerc Physiol (1983) 1.02

Respiratory control in lowlanders and Sherpa highlanders at altitude. Respir Physiol (1967) 1.02

Early surgical treatment of valvular endocarditis. JAMA (1967) 1.02

Evaluation of splenorrhaphy: a grading system for splenic trauma. J Trauma (1981) 1.02

Nocturnal periodic breathing at altitudes of 6,300 and 8,050 m. J Appl Physiol (1985) (1986) 1.02

Oxidative-stress response in vascular endothelial cells exposed to acellular hemoglobin solutions. Am J Physiol (1995) 1.02

Effect of change in P50 on exercise tolerance at high altitude: a theoretical study. J Appl Physiol Respir Environ Exerc Physiol (1982) 1.02